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Purpose: To report a case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) in a
young woman.
Observations: A 21-year-old white female patient was referred to retina clinic with decreased vision in
the left eye. On examination, best corrected visual acuity was 20/20 in the right eye and counting ﬁngers
in the left eye. Fundus examination revealed bilateral optic disc edema, peripapillary and macular ex-
udates, retinal arterial aneurysms, and venous beading. In the left eye, there was a large focus of
exudative material in the central macula. Examination of the peripheral retina was unremarkable,
bilaterally. Fluorescein angiography demonstrated arterial aneurysms and venous beading in both eyes,
with optic nerve activity and vascular sheathing noted on late frames in both eyes. In the left eye, there
was a large central area of blockage corresponding to hard exudates surrounding a more central area of
hyperﬂuorescence with leakage, representing retinal neovascularization. Review of systems and exten-
sive laboratory workup were negative. The patient was diagnosed with IRVAN. She was observed, and
her exam at 6-month follow-up revealed low grade inﬂammation for which the patient was started on
oral prednisone.
Conclusions and Importance: Management of IRVAN remains challenging because of its idiopathic nature
and the lack of controlled clinical trials for such a rare entity. Bilateral involvement in IRVAN is variable
and close follow up is crucial.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Idiopathic retinal vasculitis, aneurysms and neuroretinitis
(IRVAN) is a peculiar clinical entity where retinal arteritis with
aneurysmal dilatations, retinal ischemia with neovascularization,
neuroretinitis, uveitis, and exudative maculopathy can result in
vision loss. The disease is rare and characteristically affects young
individuals. The term idiopathic refers to the absence of associa-
tions with systemic abnormalities [1e3].
Herein, we report a case of a young womanwith IRVAN, and we
discuss our management approach.2. Case report
A 21-year-old woman with no signiﬁcant past medical history
was referred to our retina service for evaluation of blurred vision inlasil), Scott.Ketner@yale.edu
y), Ron.Adelman@yale.edu
anwu).
Inc. This is an open access article uthe left eye for the past 2 months. Patient received treatment with
oral prednisone taper and oral azithromycin by an outside
ophthalmologist with no improvement in her vision. On exam,
best-corrected visual acuity was 20/20 in the right eye and counting
ﬁngers in the left eye. Pupils were round and reactive to light with
no relative afferent papillary defect. Anterior segment exam
showed no rubeosis. Old vitreous cells were noted in both eyes.
Fundus examination revealed bilateral optic disc edema with
multiple yellowish peripapillary exudates, arterial aneurysms, and
venous beading. There was a large, discrete collection of exudative
material in the central macula of the left eye (Fig. 1). Examination of
the peripheral retina was unremarkable. Humphrey visual ﬁeld 24-
2 demonstrated enlargement of the blind spot in both eyes with
central scotoma in the left eye (Fig. 1). Spectral domain optical
coherene tomography (Spectralis OCT, Heidelberg, Germany)
showed bilateral peripapillary edema and extensive central mac-
ular edema in the left eye (Fig. 2). Fluorescein angiography revealed
arterial aneurysms and venous beading in both eyes and, in the left
eye, a large central area of hypoﬂuorescence secondary to blockage
from the exudative material, with a small, more central area of
hyperﬂuorescence with leakage, representing retinalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Color fundus photograph of the right eye shows optic disc swelling with multiple yellowish peripapillary and macular exudates, retinal edema, aneurysmal dilatations of
retinal arteries and venous beading. Color fundus photograph of the left eye shows optic nerve swelling and retinal exudates. There is a discrete collection of yellowish exudative
material causing retinal swelling and elevation with aneurysmal dilatations of the adjacent retinal arterioles. Humphrey visual ﬁeld 24-2 test demonstrates enlargement of the blind
spot in both eyes and central scotoma in the left eye. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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(Fig. 2).
Review of systems was unremarkable. Laboratory workup was
negative, including complete blood count, sedimentation rate, C-
reactive protein, angiotensin converting enzyme level, antinuclear
antibodies, Bartonella hensela, Borrelia burgdorferi, Toxoplasma
gondii, quantiferon gold, and ﬂuorescent treponemal antibody ab-
sorption tests [Table 1].
The patient was diagnosed with IRVAN. She was observed, and
her exam remained stable at the 4-month follow-up visit. At 6-
month follow up visit, the patient complained of black shadow in
the right eye which was preceded by mild viral prodrome symp-
toms. Visual acuity remained stable andold vitreous cellswereagain
noted in both eyes. Repeat FA showed increase in arterial aneurysms
in the right eye with increased vascular sheathing (Fig. 3). No pe-
ripheral neovascularization was noted. Patient was started on oral
prednisone 60 mg daily with a slow taper and close follow up.3. Discussion
IRVAN was ﬁrst described by Kincaid and Schatz in 1983 [1] and
further characterized by Chang et al., in 1995 [2]. It is a diagnosis of
exclusion. It usually affects young healthy individuals with female
predominance and usually presents in the third or fourth decade of
life. The disease has a variable course [2], with visual outcomes
ranging from 20/20 to No Light Perception [3]. The presence of
retinal vasculitis, aneurysmal arteriolar dilatations, and neuro-
retinitis represent the major criteria for diagnosing IRVAN. Macular
exudation, retinal neovascularization and peripheral capillary non-
perfusion are the minor criteria [3].Many treatment modalities have been used for IRVAN. Ster-
oidsdsystemic, periocular, and intravitreal–have yielded limited
results [3]. Systemic administration of anti-tumor necrosis factor
agent inﬂiximab has been reported effective in one instance [4].
Intravitreal injection of anti-vascular endothelial growth factor
(anti-VEGF) agents bevacizumab and ranibizumab have been used
successfully for macular edema [5e7], as grid laser has been [3,8],
though laser photocoagulation of leaking macroaneurysms is not
generally recommended because of the branch retinal artery oc-
clusion that it causes and subsequent vision loss from ischemia in
the area downstream of the lesion [3]. Multiple reports, including
review of the largest number of IRVAN cases to date (44 eyes of 22
patients) by Samuel et al., indicate the importance of panretinal
photocoagulation in the presence of widespread retinal ischemia to
prevent neovascularization and subsequent vitreous hemorrhage
and neovascular glaucoma [3,8]. Nevertheless, the treatment of
IRVAN represents a challenge to the retinal specialist, because of
the idiopathic nature of the disorder and the lack of controlled
clinical trials in such a rare entity.
Our case illustrates the asymmetry between two eyes of a single
patient that may be found in IRVAN. While the right eye was
initially asymptomatic with 20/20 visual acuity, the left eye visual
acuity ranged between 20/400 eccentric and counting ﬁngers.
Because the macular exudation in the left eye of our patient was so
massive, central, and chronic (color photographs demonstrate the
mineralization of some of the exudates on the superotemporal edge
of the collection of material, Fig.1), intravitreal injections of an anti-
VEGF agent were thought unlikely to improve vision, and the pa-
tient opted for observation. Interestingly, her 6 month follow up
exam revealed mild visual symptoms in her right eye and increase
in arterial aneurysmal dilation and vascular sheathing after viral
Fig. 2. Multimodal imaging at initial presentation Spectral domain optical coherence tomography shows peripapillary macular edema OD and nasal macular edema with extensive
central intraretinal exudates causing artifact due to blockage of the signal OS. Fluorescein angiogram of the right eye at 39 s (recirculation phase) is showing aneurysmal dilatations of
retinal arteries and venous beading. Fluorescein angiogram of the left eye at 17 s (arterial phase) shows aneurysmal dilatations of retinal arteries and central macular hypoﬂuor-
escence (due to blockage from exudation) with a focal area of temporal hyperﬂuorescence (corresponding to mineralized exudates). At later frames (after 4 min) there is persistent
central macular hypoﬂuorescence with hyperﬂuorescence within the center corresponding to neovascularization. Bilateral optic nerve activity and vascular sheathing are noted.
Table 1
Laboratory workup completed prior to establishing the diagnosis of idiopathic retinal vasculitisaneurysms and neuroretinitis syndrome in Table 21-year-old
woman.
Laboratory workup Results Reference range
WBC 3.93 (L) 4.80e10.80  10 (3)/mcL
Hemoglobin 13.6 12.0e15.0 g/dL
Hematocrit 40.1 36.0e48.0%
MCV 89.7 81.0e99.0 FL
Platelets 242 120e450  10 (3)/mcL
MPV 11.0 (H) 8.5e9.0 FL
C-Reactive Protein <5 0.0e10.0 mg/L
ESR 5 0e20 mm/h
Angiotensin Converting Enzyme 17 8e53 unit/L
Bartonella henselae Ab IgM <1:20 <1:20
Bartonella henselae Ab IgG <1:64 <1:64
RPR Non reactive Non reactive
Borrelia burgdorferi Ab 0.19 0.00e0.99 index
Antinuclear Ab <1:40 0.00e0.99 index
Toxoplasmosis gondii Ab IgM 0.3 0.00e0.99 index
Toxoplasmosis gondii Ab IgG 0.08 0.00e0.99 index
Ehrlichia chaffeensis Ab IgG <1:64 <1:64
Ehrlichia chaffeensis Ab IgM <1:20 <1:20
Quantiferon gold test Negative Negative
Fluorescent treponemal Ab (IgG and IgM) absorption test Non reactive Non reactive
Abbreviation: Ab, antibody.
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inﬂammation. No neovascularizationwas noted in the right eye and
the central area of neovascularization in the left eye remained
stable. Oral prednisone was initiated and she will continue to bemonitored closely for any sign of increased inﬂammation or any
indication of peripheral retinal ischemia, at which point panretinal
photocoagulation would be indicated.
Fig. 3. Multimodal imaging at 6 month follow up Spectral domain optical coherence tomography shows peripapillary macular edema OD and nasal macular edema with extensive
central intraretinal exudates OS. Fluorescein angiogram of the right eye (at recirculation phase) is showing aneurysmal dilatations of retinal arteries and venous beading. Fluorescein
angiogram of the left eye (at recirculation phase) shows aneurysmal dilatations of retinal arteries and venous beading with central macular hypoﬂuorescence (due to blockage from
exudation) with a focal area of temporal hyperﬂuorescence (corresponding to mineralized exudates) and hyperﬂuorescence within the center corresponding to neovascularization.
Late phase ﬂuorescein angiogram frames are showing activity at both optic nerves and vascular sheathing (red rectangle). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
T. Alasil et al. / American Journal of Ophthalmology Case Reports 2 (2016) 33e3636Authors' contributions
All authors contributed signiﬁcantly to the creation of this
manuscript; each fulﬁlled criteria as established by the ICMJE.
Consent to publish
Informed consent was obtained in writing from the patient for
the use of their information and external photograph for the pur-
pose of this report.
Acknowledgment and support
The presented material received support from RPB “Research to
Prevent Blindness” grant.
References
[1] J. Kincaid, H. Schatz, Bilateral retinal arteritis with multiple aneurysmal di-
latations, Retina 3 (3) (1983) 171e178.[2] T.S. Chang, G.W. Aylward, J.L. Davis, W.F. Mieler, G.L. Oliver, A.L. Maberley, et al.,
Idiopathic retinal vasculitis, aneurysms and neuroretinitis, Ophthalmology 102
(1995) 1089e1097.
[3] M.A. Samuel, R.A. Equi, T.S. Chang, W. Mieler, L.M. Jampol, D. Hay, et al., Idio-
pathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new obser-
vations and a proposed staging system, Ophthalmology 114 (2007) 1526e1529.
[4] R.A. Cheema, E. Al-Askar, H.R. Cheema, Inﬂiximab therapy for idiopathic retinal
vasculitis, aneurysm, and neuroretinitis syndrome, J. Ocul. Pharmacol. Ther. 27
(4) (2011) 407e410.
[5] H. Faghihi, et al., Idiopathic retinal vasculitis, aneurysms and neuroretinitis: a
signiﬁcant increase in visual acuity after treatment with one session of pan-
retinal photocoagulation, retinopexy, and three consecutive bevacizumab in-
jections, Iran. J. Ophthalmol. 24 (2) (2012) 65e71.
[6] C. Marin-Lambies, R. Gallego-Pinazo, D. Salom, J. Navarrete, M. Diaz-Llopis,
Rapid regression of exudative maculopathy in idiopathic retinitis, vasculitis,
aneurysms and neuroretinitis syndrome after intravitreal ranibizumab, Case
Rep. Ophthalmol. 3 (2) (2012 May-Aug) 251e257.
[7] D. Karagiannis, V. Soumplis, I. Georgalas, A. Kandarakis, Ranibizumab for idio-
pathic retinal vasculitis, aneurysms, and neuroretinitis: favorable results, Eur. J.
Ophthalmol. 20 (4) (2010 Jul-Aug) 792e794.
[8] A. Rouvas, E. Nikita, N. Markomichelakis, P. Theodossiadis, N. Pharmakakis,
Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis:
clinical course and treatment, J. Ophthalmic Inﬂamm. Infect. 3 (2013) 21.
